PYOSTACINE Side Effects

6248953-3 | Leukocytoclastic Vasculitis
on Jun 15, 2009 Male patient from , 52 years of age, was diagnosed with erysipelas and was treated with Pyostacine (View Usage). Patient experienced the following unwanted or unexpected effects: leukocytoclastic vasculitis. Pyostacine dosage: . During the same period patient was treated with TORENTAL (View Torental Review and Torental Label ), TRACLEER (View Tracleer Review and Tracleer Label ). Patient was hospitalized.

6209987-8 | Colitis, International Normalised Ratio Increased, Rectal Haemorrhage
Patient was taking Pyostacine (View Usage). Patient had the following side effects: colitis, international normalised ratio increased, rectal haemorrhage on May 25, 2009 from Additional patient health information: Female patient , 84 years of age, was diagnosed with thrombosis and. Pyostacine dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), HYDROCORTISONE /00028607/ (View Hydrocortisone /00028607/ Review and Hydrocortisone /00028607/ Label ), PREVISCAN /00789001/ (View Previscan /00789001/ Review and Previscan /00789001/ Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), CLAMOXYL /00249601/ (View Clamoxyl /00249601/ Review and Clamoxyl /00249601/ Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TOPALGIC (View Topalgic Review and Topalgic Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ). Patient was hospitalized.

6165594-7 | Erythema, Skin Exfoliation, Toxic Epidermal Necrolysis
Adverse event was reported on Apr 09, 2009 by a Female patient taking Pyostacine (View Usage) (Dosage: ) was diagnosed with hyperthermia, arthralgia and. Location: , 80 years of age, After Pyostacine was administered, patient had the following side effects: erythema, skin exfoliation, toxic epidermal necrolysis. During the same period patient was treated with LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), CORTANCYL (View Cortancyl Review and Cortancyl Label ), NORSET (View Norset Review and Norset Label ), PRAZEPAM (View Prazepam Review and Prazepam Label ), LEPTICUR (View Lepticur Review and Lepticur Label ), CELECTOL (View Celectol Review and Celectol Label ), LAXATIVES (View Laxatives Review and Laxatives Label ), PREVISCAN /00789001/ (View Previscan /00789001/ Review and Previscan /00789001/ Label ). Patient was hospitalized.

6072075-8 | Colitis, International Normalised Ratio Increased, Rectal Haemorrhage
on Feb 02, 2009 Female patient from , 84 years of age, was diagnosed with thrombosis and was treated with Pyostacine (View Usage). Patient experienced the following unwanted or unexpected effects: colitis, international normalised ratio increased, rectal haemorrhage. Pyostacine dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), HYDROCORTISONE /00028607/ (View Hydrocortisone /00028607/ Review and Hydrocortisone /00028607/ Label ), PREVISCAN /00789001/ (View Previscan /00789001/ Review and Previscan /00789001/ Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), CLAMOXYL /00249601/ (View Clamoxyl /00249601/ Review and Clamoxyl /00249601/ Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), TOPALGIC (View Topalgic Review and Topalgic Label ), BRICANYL (View Bricanyl Review and Bricanyl Label ). Patient was hospitalized.


5700620-8 | Fall, Nausea
on Apr 01, 2008 Female patient from , 52 years of age, was treated with Pyostacine (View Usage). Patient had the following side effects: fall (What is fall?), nausea (What is nausea?). Pyostacine dosage: . During the same period patient was treated with KETEK (View Ketek Review and Ketek Label ), FLANID (View Flanid Review and Flanid Label ). Patient was hospitalized.

5641071-4 | Condition Aggravated, Rash Pustular
Patient was taking Pyostacine (View Usage). After Pyostacine was administered, patient had the following side effects: condition aggravated, rash pustular on Feb 18, 2008 from Additional patient health information: Female patient , 94 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Pyostacine dosage: . During the same period patient was treated with LASILIX /00032601/ (View Lasilix /00032601/ Review and Lasilix /00032601/ Label ), LANZOR (View Lanzor Review and Lanzor Label ), CORDARONE (View Cordarone Review and Cordarone Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), TIAPRIDAL /00435701/ (View Tiapridal /00435701/ Review and Tiapridal /00435701/ Label ), FORLAX (View Forlax Review and Forlax Label ), NOCTRAN (View Noctran Review and Noctran Label ), DERMOVAL /00337102/ (View Dermoval /00337102/ Review and Dermoval /00337102/ Label ). Patient was hospitalized.

5585627-6 | Condition Aggravated, Rash Pustular
Adverse event was reported on Jan 02, 2008 by a Female patient taking Pyostacine (View Usage) (Dosage: ) was diagnosed with atrial fibrillation (What is atrial fibrillation?) and. Location: , 94 years of age, Patient experienced the following unwanted or unexpected effects: condition aggravated, rash pustular. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), LANZOR (View Lanzor Review and Lanzor Label ), CORDARONE (View Cordarone Review and Cordarone Label ), KARDEGIC /00002703/ (View Kardegic /00002703/ Review and Kardegic /00002703/ Label ), TIAPRIDAL /00435701/ (View Tiapridal /00435701/ Review and Tiapridal /00435701/ Label ), FORLAX (View Forlax Review and Forlax Label ), NOCTRAN (View Noctran Review and Noctran Label ), DERMOVAL /00337102/ (View Dermoval /00337102/ Review and Dermoval /00337102/ Label ). Patient was hospitalized.

5472754-7 | Asthenia, Eosinophilia, Face Oedema, Inflammation, Nephritis Interstitial, Odynophagia, Pruritus, Purpura
on Sep 21, 2007 Male patient from , 71 years of age, was diagnosed with prophylaxis, urinary retention, insomnia and was treated with Pyostacine (View Usage). Patient had the following side effects: asthenia, eosinophilia, face oedema, inflammation, nephritis interstitial, odynophagia, pruritus, purpura. Pyostacine dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), JOSIR (View Josir Review and Josir Label ), GAVISCON /01405501/ (View Gaviscon /01405501/ Review and Gaviscon /01405501/ Label ), RIFADIN (View Rifadin Review and Rifadin Label ), OFLOCET /00731801/ (View Oflocet /00731801/ Review and Oflocet /00731801/ Label ), IMOVANE (View Imovane Review and Imovane Label ), TOPALGIC (View Topalgic Review and Topalgic Label ). Patient was hospitalized.

5276883-2 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Liver Disorder, Pruritus
on Mar 22, 2007 Female patient from , 40 years of age, weighting 238.1 lb, was treated with Pyostacine (View Usage). After Pyostacine was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, liver disorder, pruritus. Pyostacine dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), DAFALGAN /00020001/ (View Dafalgan /00020001/ Review and Dafalgan /00020001/ Label ). Patient was hospitalized.

5217041-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Gamma-glutamyltransferase Increased, Liver Disorder, Pruritus
Patient was taking Pyostacine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, gamma-glutamyltransferase increased, liver disorder, pruritus on Jan 19, 2007 from Additional patient health information: Female patient , 40 years of age, weighting 238.1 lb, . Pyostacine dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), DAFALGAN /00020001/ (View Dafalgan /00020001/ Review and Dafalgan /00020001/ Label ). Patient was hospitalized.

5107736-8 | Abdominal Pain, Abdominal Pain Upper, Chromaturia, Deafness Bilateral, Diarrhoea, Faeces Discoloured, Gastrointestinal Disorder, Nausea, Skin Reaction
Adverse event was reported on Jan 04, 2006 by a Male patient taking Pyostacine (View Usage) (Dosage: ) was diagnosed with osteomyelitis, device related infection, cardiac valve disease, glaucoma (What is glaucoma?) and. Location: FRANCE , 60 years of age, Patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, chromaturia, deafness bilateral, diarrhoea, faeces discoloured, gastrointestinal disorder, nausea (What is nausea?), skin reaction. During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), LANZOR (View Lanzor Review and Lanzor Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), CARTEOLOL HCL (View Carteolol Hcl Review and Carteolol Hcl Label ).

5102393-9 | Abdominal Pain, Abdominal Pain Upper, Chromaturia, Condition Aggravated, Deafness Bilateral, Diarrhoea, Faeces Discoloured, Gastrointestinal Disorder, Nausea
on Jan 04, 2006 Male patient from FRANCE , 60 years of age, was diagnosed with osteomyelitis, device related infection, cardiac valve disease, glaucoma (What is glaucoma?) and was treated with Pyostacine (View Usage). After Pyostacine was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), abdominal pain upper, chromaturia, condition aggravated, deafness bilateral, diarrhoea, faeces discoloured, gastrointestinal disorder, nausea (What is nausea?). Pyostacine dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), LANZOR (View Lanzor Review and Lanzor Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), CARTEOLOL HCL (View Carteolol Hcl Review and Carteolol Hcl Label ).

5098237-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Lactate Dehydrogenase Increased, Gamma-glutamyltransferase Increased, Liver Disorder, Pruritus, Rash
on Aug 30, 2006 Female patient from , 40 years of age, weighting 238.1 lb, was diagnosed with erysipelas and was treated with Pyostacine (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood lactate dehydrogenase increased, gamma-glutamyltransferase increased, liver disorder, pruritus, rash (What is rash?). Pyostacine dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), DAFALGAN (View Dafalgan Review and Dafalgan Label ). Patient was hospitalized.

5073484-6 | Deafness Bilateral, Headache, Visual Field Defect
Patient was taking Pyostacine (View Usage). Patient had the following side effects: deafness bilateral, headache (What is headache?), visual field defect on Jan 04, 2006 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with osteomyelitis, infection (What is infection?), glaucoma (What is glaucoma?) and. Pyostacine dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), LANZOR (View Lanzor Review and Lanzor Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), CARTEOLOL HCL (View Carteolol Hcl Review and Carteolol Hcl Label ).

4971560-7 | Deafness Bilateral, Tinnitus, Visual Field Defect
Adverse event was reported on Jan 04, 2006 by a Male patient taking Pyostacine (View Usage) (Dosage: ) was diagnosed with osteomyelitis, device related infection and. Location: FRANCE , 60 years of age, After Pyostacine was administered, patient had the following side effects: deafness bilateral, tinnitus (What is tinnitus?), visual field defect. During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), LANZOR (View Lanzor Review and Lanzor Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), CARTEOLOL HCL (View Carteolol Hcl Review and Carteolol Hcl Label ).

4941584-4 | Acute Respiratory Distress Syndrome, Eosinophilia, Erythema, Hyperglycaemia, Hypersensitivity, Leukocytosis, Renal Failure, Toxic Skin Eruption
on Apr 07, 2005 Male patient from , 54 years of age, was diagnosed with bronchial disorder and was treated with Pyostacine (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, eosinophilia, erythema, hyperglycaemia, hypersensitivity, leukocytosis, renal failure, toxic skin eruption. Pyostacine dosage: . During the same period patient was treated with KETEK (View Ketek Review and Ketek Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

4912317-2 | Eosinophilia, Pruritus, Subcutaneous Nodule
on Dec 15, 2005 Male patient from , 46 years of age, was diagnosed with device related infection, staphylococcal infection (What is staphylococcal infection?) and was treated with Pyostacine (View Usage). Patient had the following side effects: eosinophilia, pruritus, subcutaneous nodule. Pyostacine dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), TAVANIC (View Tavanic Review and Tavanic Label ), FRAXODI (View Fraxodi Review and Fraxodi Label ), LEXOMIL (View Lexomil Review and Lexomil Label ). Patient was hospitalized.

4886128-0 | Deafness Bilateral, Visual Field Defect
Patient was taking Pyostacine (View Usage). After Pyostacine was administered, patient had the following side effects: deafness bilateral, visual field defect on Jan 04, 2006 from FRANCE Additional patient health information: Male patient , 60 years of age, was diagnosed with osteomyelitis, device related infection, glaucoma (What is glaucoma?) and. Pyostacine dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), LANZOR (View Lanzor Review and Lanzor Label ), GAVISCON (View Gaviscon Review and Gaviscon Label ), CARTEOLOL HCL (View Carteolol Hcl Review and Carteolol Hcl Label ).

4882248-5 | Agranulocytosis, Alanine Aminotransferase Increased, Hepatocellular Damage
Adverse event was reported on Jan 06, 2006 by a Male patient taking Pyostacine (View Usage) (Dosage: ) was diagnosed with bacterial infection (What is bacterial infection?), sinusitis (What is sinusitis?), brain abscess, meningitis (What is meningitis?) and. Location: , 15 years of age, weighting 132.3 lb, Patient experienced the following unwanted or unexpected effects: agranulocytosis, alanine aminotransferase increased, hepatocellular damage. During the same period patient was treated with CLAFORAN (View Claforan Review and Claforan Label ), FLAGYL (View Flagyl Review and Flagyl Label ), FOSFOCINE (View Fosfocine Review and Fosfocine Label ). Patient was hospitalized.

4871598-4 | Aphthous Stomatitis, Face Oedema, Rash Pruritic, Skin Test Positive
on Dec 28, 2005 Female patient from , 55 years of age, was treated with Pyostacine (View Usage). Patient had the following side effects: aphthous stomatitis, face oedema, rash pruritic, skin test positive. Pyostacine dosage: . During the same period patient was treated with RIFADIN (View Rifadin Review and Rifadin Label ). Patient was hospitalized.

4865103-6 | Eosinophilia, Pruritus, Subcutaneous Nodule
on Dec 15, 2005 Male patient from , 46 years of age, was diagnosed with device related infection, staphylococcal infection (What is staphylococcal infection?) and was treated with Pyostacine (View Usage). After Pyostacine was administered, patient had the following side effects: eosinophilia, pruritus, subcutaneous nodule. Pyostacine dosage: . During the same period patient was treated with LOVENOX (View Lovenox Review and Lovenox Label ), TAVANIC (View Tavanic Review and Tavanic Label ), FRAXODI (View Fraxodi Review and Fraxodi Label ), LEXOMIL (View Lexomil Review and Lexomil Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

4638796-6 | Acute Respiratory Distress Syndrome, Eosinophilia, Hypersensitivity
Patient was taking Pyostacine (View Usage). Patient experienced the following unwanted or unexpected effects: acute respiratory distress syndrome, eosinophilia, hypersensitivity on Apr 07, 2005 from Additional patient health information: Male patient , 54 years of age, was diagnosed with bronchitis (What is bronchitis?) and. Pyostacine dosage: . During the same period patient was treated with KETEK (View Ketek Review and Ketek Label ), AUGMENTIN '125' (View Augmentin '125' Review and Augmentin '125' Label ). Patient was hospitalized.

4549422-9 | Dermatitis Exfoliative, Lymphadenitis
Adverse event was reported on Jan 04, 2005 by a Female patient taking Pyostacine (View Usage) (Dosage: ) was diagnosed with chronic obstructive pulmonary disease, tooth extraction and. Location: , 76 years of age, weighting 110.2 lb, Patient had the following side effects: dermatitis exfoliative, lymphadenitis. During the same period patient was treated with ORELOX (View Orelox Review and Orelox Label ), BIRODOGYL (View Birodogyl Review and Birodogyl Label ), AUGMENTIN (View Augmentin Review and Augmentin Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ), FLANID (View Flanid Review and Flanid Label ), XYZALL /AUT/ (View Xyzall /aut/ Review and Xyzall /aut/ Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.